Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity

FEBS Journal

Volumn 280, Issue 22, 2013, Pages 5829-5840

  Ou, Jun Lin ^a   Mizushina, Yoshiyuki ^b   Wang, Sheng Yang ^a   Chuang, Duen Yau ^a   Nadar, Muthukumar ^c   Hsu, Wei Li ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b KOBE GAKUIN UNIVERSITY   (Japan)

^c KARUNYA UNIVERSITY   (India)

Author keywords

curcumin; influenza virus; simulation docking; structure analogue; structure activity relationship

Indexed keywords

ANTIVIRUS AGENT; CURCUMIN; CURCUMIN DERIVATIVE; GLUTATHIONE; GLUTATHIONE DISULFIDE; INFLUENZA VIRUS HEMAGGLUTININ; PETASIPHENOL; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; INFLUENZA VIRUS A; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS PLAQUE;

CURCUMIN; INFLUENZA VIRUS; SIMULATION DOCKING; STRUCTURE ANALOGUE; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALS; ANTIVIRAL AGENTS; BINDING SITES; CAFFEIC ACIDS; CURCUMIN; DOGS; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL PLAQUE ASSAY;

ORTHOMYXOVIRIDAE;

EID: 84886598830     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12503     Document Type: Article

References (40)

1. Aggarwal BB, Kumar A, &, Bharti AC, (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23, 363-398.
2. Aggarwal BB, &, Sung B, (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30, 85-94.
3. Goel A, Kunnumakkara AB, &, Aggarwal BB, (2007) Curcumin as 'curecumin': from kitchen to clinic. Biochem Pharmacol 75, 787-809.
4. Chen DY, Shien JH, Tiley L, Chiou SS, Wang SY, Chang TJ, Lee YJ, Chan KW, &, Hsu WL, (2010) Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem 119, 1346-1351.
5. Si X, Wang Y, Wong J, Zhang J, McManus BM, &, Luo H, (2007) Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol 81, 3142-3150.
6. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, &, Pardee AB, (1993) Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90, 1839-1842.
7. Kutluay SB, Doroghazi J, Roemer ME, &, Triezenberg SJ, (2008) Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology 373, 239-247.
8. Mazumder A, Raghavan K, Weinstein J, Kohn KW, &, Pommier Y, (1995) Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49, 1165-1170.
9. Pan MH, Huang TM, &, Lin JK, (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27, 486-494.
10. Hoehle SI, Pfeiffer E, Solyom AM, &, Metzler M, (2006) Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 54, 756-764.
11. Singh S, &, Aggarwal BB, (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270, 24995-25000.
12. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, &, Price JE, (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490-7498.
13. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, &, Aggarwal BB, (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28, 1765-1773.
14. Mizushina Y, Kamisuki S, Kasai N, Ishidoh T, Shimazaki N, Takemura M, Asahara H, Linn S, Yoshida S, Koiwai O, et al,. (2002) Petasiphenol: a DNA polymerase lambda inhibitor. Biochemistry (Mosc) 41, 14463-14471.
15. Chen TY, Chen DY, Wen HW, Ou JL, Chiou SS, Chen JM, Wong ML, &, Hsu WL, (2013) Inhibition of enveloped viruses infectivity by curcumin. PLoS One 8, e62482.
16. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, &, Santoro MG, (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403, 103-108.
17. Srinivasan B, Johnson TE, Lad R, &, Xing C, (2009) Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3′,4′, 5′-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. J Med Chem 52, 7228-7235.
18. Kalantari P, Narayan V, Henderson AJ, &, Prabhu KS, (2009) 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification. FASEB J 23, 2366-2373.
19. Narayan V, Ravindra KC, Chiaro C, Cary D, Aggarwal BB, Henderson AJ, &, Prabhu KS, (2011) Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication. J Mol Biol 410, 972-983.
20. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, &, Lin JK, (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15, 1867-1876.
21. Luig C, Kother K, Dudek SE, Gaestel M, Hiscott J, Wixler V, &, Ludwig S, (2010) MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR. FASEB J 24, 4068-4077.
22. Ludwig S, Planz O, Pleschka S, &, Wolff T, (2003) Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol Med 9, 46-52.
23. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, &, Ludwig S, (2001) Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 3, 301-305.
24. Ludwig S, &, Planz O, (2008) Influenza viruses and the NF-kappaB signaling pathway-towards a novel concept of antiviral therapy. Biol Chem 389, 1307-1312.
25. Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, &, Ludwig S, (2007) Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol 9, 1683-1694.
26. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, &, Ludwig S, (2007) Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 81, 3058-3067.
27. Ehrhardt C, &, Ludwig S, (2009) A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell Microbiol 11, 863-871.
28. Wu JC, Lai CS, Badmaev V, Nagabhushanam K, Ho CT, &, Pan MH, (2011) Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol Nutr Food Res 55, 1646-1654.
29. Ito Y, Pandey P, Sporn MB, Datta R, Kharbanda S, &, Kufe D, (2001) The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol Pharmacol 59, 1094-1099.
30. Konopleva M, Tsao T, Ruvolo P, Stiouf I, Estrov Z, Leysath CE, Zhao S, Harris D, Chang S, Jackson CE, et al,. (2002) Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood 99, 326-335.
31. Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, Suh N, Williams C, Risingsong R, Honda T, Gribble GW, et al,. (2005) Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci USA 102, 4584-4589.
32. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, &, Talalay P, (2001) Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 98, 3404-3409.
33. Soundararajan V, Zheng S, Patel N, Warnock K, Raman R, Wilson IA, Raguram S, Sasisekharan V, &, Sasisekharan R, (2011) Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci Rep 1, 200.
34. Ehrhardt C, Ruckle A, Hrincius ER, Haasbach E, Anhlan D, Ahmann K, Banning C, Reiling SJ, Kuhn J, Strobl S, et al,. (2013) The NF-kappaB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance. Cell Microbiol 15, 1198-1211.
35. Lin CT, Senthil Kumar KJ, Tseng YH, Wang ZJ, Pan MY, Xiao JH, Chien SC, &, Wang SY, (2009) Anti-inflammatory activity of flavokawain B from Alpinia pricei Hayata. J Agric Food Chem 57, 6060-6065.
36. Wang SY, Chen PF, &, Chang ST, (2005) Antifungal activities of essential oils and their constituents from indigenous cinnamon (Cinnamomum osmophloeum) leaves against wood decay fungi. Bioresour Technol 96, 813-818.
37. Chen YJ, Shiao MS, &, Wang SY, (2001) The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs 12, 143-149.
38. Zheng W, &, Wang SY, (2001) Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem 49, 5165-5170.
39. Wang SY, Lan XY, Xiao JH, Yang JC, Kao YT, &, Chang ST, (2008) Antiinflammatory activity of Lindera erythrocarpa fruits. Phytother Res 22, 213-216.
40. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, &, Olson AJ, (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30, 2785-2791.